ストックスクリーナーアプリを入手
6.88
2.99%
0.20
アフターアワーズ：
6.89
0.010
+0.15%
前日終値:
$6.68
開ける：
$6.92
24時間の取引高:
902.64K
Relative Volume:
0.32
時価総額：
$745.75M
収益：
$42.51M
当期純損益:
$-116.49M
株価収益率:
-6.1429
EPS:
-1.12
ネットキャッシュフロー:
$-120.82M
1週間 パフォーマンス:
+8.35%
1か月 パフォーマンス:
+29.32%
6か月 パフォーマンス:
+125.57%
1年 パフォーマンス:
-29.44%
1日の値動き範囲:
$6.85
$7.09
1週間の範囲:
$6.36
$7.14
52週間の値動き範囲:
$1.03
$12.02
Tango Therapeutics Inc Stock (TNGX) Company Profile
TNGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
6.88 | 724.07M | 42.51M | -116.49M | -120.82M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-17 | 開始されました | Jefferies | Buy |
| 2024-04-04 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-12 | 開始されました | Piper Sandler | Overweight |
| 2023-12-08 | 開始されました | B. Riley Securities | Buy |
| 2022-10-20 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Tango Therapeutics Inc (TNGX) 最新ニュース
Is Tango Therapeutics Inc. a good long term investmentFree Trading Strategy Suggestions - Autocar Professional
What analysts say about Tango Therapeutics Inc. stockTremendous growth potential - jammulinksnews.com
Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025 - GlobeNewswire
What drives Tango Therapeutics Inc. stock priceFree Consultation - jammulinksnews.com
Will Tango Therapeutics Inc. stock benefit from interest rate changesMarket Timing Advice - Newser
How Tango Therapeutics Inc. stock performs during market volatilityFree Consultation - Newser
Tango Therapeutics Inc. Stock Analysis and ForecastAccelerated financial growth - jammulinksnews.com
How high can Tango Therapeutics Inc. stock price go in 2025Daily Volume Leaders - Newser
Can Tango Therapeutics Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect? - MSN
What makes Tango Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser
Why Tango Therapeutics Inc. stock attracts strong analyst attentionFree Capital Growth Strategies - Newser
Tango Therapeutics (TNGX) Soars 5.96% on Strong Q2 Earnings - AInvest
Tango Therapeutics’ SWOT analysis: biotech stock’s potential in precision cancer therapies - Investing.com
Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last? - MSN
HC Wainwright Issues Optimistic Forecast for TNGX Earnings - Defense World
Tango Therapeutics, Inc.(NasdaqGM: TNGX) added to Russell 3000 Value Index - MarketScreener
H.C. Wainwright reiterates Buy rating on Tango Therapeutics stock - Investing.com
Tango Therapeutics Announces First Patient Dosed in Phase - GlobeNewswire
Tango Therapeutics Launches Groundbreaking Trial for Advanced Pancreatic and Lung Cancer Treatment - Stock Titan
Exchange Traded Concepts LLC Purchases 47,901 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World
Tango Therapeutics' Mysterious 7.5% Spike: What’s Behind the Move? - AInvest
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Tango Therapeutics’ SWOT analysis: stock poised for growth amid clinical trials - Investing.com
Two Sigma Investments LP Sells 23,166 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World
B. Riley Increases Earnings Estimates for Tango Therapeutics - Defense World
What is B. Riley’s Forecast for TNGX Q2 Earnings? - Defense World
Squarepoint Ops LLC Makes New $40,000 Investment in Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World
Two Sigma Advisers LP Takes Position in Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World
Tango Therapeutics, Inc. (NASDAQ:TNGX) Stock Holdings Increased by Bank of America Corp DE - Defense World
Tango Therapeutics Inc (TNGX) 財務データ
収益
当期純利益
現金流量
EPS
4.91%
0.25%
大文字化:
|
ボリューム (24 時間):